PB
Paul Blenkinsopp
Director at Ionoptika
View Paul's Contact Info for Free. Sign Up and Get 50 Free Contacts Per Month.Get Started for Free
Work Experience
Director
1994 - Present · 31 years
Company Details
11-50 Employees
As specialists in Ion Beam Technology, we constantly strive to deliver new and innovative technologies to power the discoveries of tomorrow. Established in 1994, Ionoptika are one of the leading providers of high-performance ion beam technologies for surface analysis and nanofabrication applications, and are the experts in cluster ion beams for secondary ion mass spectrometry (SIMS). Our unique water cluster beam is at the cutting edge of Mass Spec Imaging, enabling discovery in drug discovery, lipidomics, multi-omics and materials research. We are also known as the developers of the Q-One, a state-of-the-art tool for deterministic single ion implantation with nanoscale precision. Featuring a host of powerful features, the Q-One is the most advanced system for fabrication of quantum devices and advanced materials engineering. Our product range extends from instrumentation, to individual ion beam systems, components, and accessories. We actively encourage collaboration, and are proud to have worked with some of the brightest minds in the scientific community. If you have a project in mind that we might be able to help with, we’d be delighted to hear from you.
Year Founded
1993
Social Media
LinkedinFacebookTwitter
Industry
Measuring and Control Instrument Manufacturing
HQ Location
Unit B6, Millbrook Close Eagle Close, Chandlers Ford Southampton, Hampshire SO53 4BZ, GB
Keywords
ion beam systemsToF SIMSion implantationcluster ion beamsMass Spec Imagingand scientific research
Discover More About Cleveland Clinic
Contact Details
  • Email AddressP**@ionoptika.com
    Reveal Email
  • Phone Number(xxx)xxx-xxxx
    Reveal Phone

Find verified contacts of Paul Blenkinsopp in seconds from 700M people profiles. Start now!

No Credit Card Needed. By signing up, you understand and agree to Futern's Terms and Policy.